ArticleRadiology case reports2026
A case of hepatic segmental atrophy mimicking spontaneously necrotized hepatocellular carcinoma.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a rare case of hepatic segmental atrophy that was initially suspected to be hepatocellular carcinoma (HCC). An 80-year-old man presented with a new 3 cm hepatic lesion that met LI-RADS-5 criteria. However, follow-up CT performed 1 month later showed loss of arterial hyperenhancement, progressive delayed peripheral enhancement, and a reduction in lesion size. MRI subsequently demonstrated high signal intensity on T2-weighted and diffusion-weighted images, without true diffusion restriction. Based on these imaging features, spontaneous necrosis of scirrhous-type HCC was suspected, and surgical resection was undertaken. Histopathological examination revealed hepatic segmental atrophy with no evidence of malignancy. Segmental atrophy can closely mimic HCC on imaging, potentially leading to misdiagnosis and unnecessary surgery. Careful evaluation of atypical features-such as the absence of true washout, lack of restricted diffusion, disproportionate capsule-like structures, and progressive morphological changes-may assist in distinguishing segmental atrophy from malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.